CARDLYTICS, INC. (CDLX) Total liabilities 2017–2025
CARDLYTICS, INC. (CDLX) total liabilities at each fiscal year-end, per SEC filings.
$292.1MFY2025 · since FY2017: $309.4M → $292.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $292.1M | -9.5% |
| FY2024 | $322.7M | -26.5% |
| FY2023 | $439.3M | -8.4% |
| FY2022 | $479.6M | -16.3% |
| FY2021 | $573.1M | +116.0% |
| FY2020 | $265.3M | +227.4% |
| FY2019 | $81.0M | -20.4% |
| FY2018 | $101.8M | -67.1% |
| FY2017 | $309.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CDLX financial trends
CDLX RevenueCDLX Net incomeCDLX Net marginCDLX Gross profitCDLX Gross marginCDLX Operating incomeCDLX Operating marginCDLX Operating cash flowCDLX Free cash flowCDLX Capital expendituresCDLX Return on equityCDLX Stock buybacksCDLX Dividends paidCDLX Total assetsCDLX Shareholders’ equityCDLX overview →